Not available outside of the UK & Ireland.
Biochem/physiol Actions
SC-51089 is a selective EP1 prostanoid receptor antagonist.
Features and Benefits
This compound was developed by Pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Legal Information
Pfizer is a registered trademark of Pfizer, Inc.
Sold for research purposes under agreement from Pfizer Inc.
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: